7Bybee KY,Wrightr S,Kopecky SL.Effect of early stain therapy after actue coronary syndromes:a concise Yeview of the recent data[J].Cardiol Rew,2002,10:301-305.
4Frohich M , Sund SB , Thorand B , et al . Lack of seasonal variation in C-reactive protein [J]. Clin Chem, 2002,48 ( 11 ) :575-577.
5Aunk T , Assayag EB , Rotsein R , et al. Prognostic implications of admision inflamatory profile in acute ischemic neurological events[J].Acta Neurol Scand , 2002,106(4):196-199.
6Vilahur G, Herndaemia induces cardiac modified C-reactive protein expression and proinflammatory gene ( cyclo-oxygenase-2, monocyte chemoattractant protein-1, and tissue factor) upreg- ulation in peripheral blood mononuclear cells [J]. J Thromb Haemost, 2009, 7(3): 485-493.
7Andersson J, Johansson L, Ladenvall P, et al. C-reactive protein is a determinant of first-ever stroke: prospective nested case-referent study [J]. Cerebrovasc Dis, 2009, 27(6): 544- 551.
8Krysiak R, Okopiefl B. Pleiotropic effects oir angiotensin-convetting enzyme inhibitors in normotensive patients with coronaryartery disease[J]. Pharmacol Rep, 2008, 60(4): 514 523.
10Farbiszewski R, Dudek H, Skrzydlewska E, et al. The role of platelet activating factor (PAF) in physiology and pathology of the central nervous system [J]. Neurol Neurochir Pol, 2002, 36(4) : 801-808.
2Stefan Blankenberg,Gérald Luc,Pierre Ducimetière,Dominique Arveiler,Jean Ferrières,Philippe Amouyel,Alun Evans,Fran?ois Cambien,Laurence Tiret.Interleukin-18 and the Risk of Coronary Heart Disease in European Men: The Prospective Epidemiological Study of Myocardial Infarction (PRIME)[J].Circulation: Journal of the American Heart Association.2003(20)
3Irene M. van der Meer,Moniek P.M. de Maat,A. Elisabeth Hak,Amanda J. Kiliaan,Antonio Iglesias del Sol,Deirdre A.M. van der Kuip,Rogier L.G. Nijhuis,Albert Hofman,Jacqueline C.M. Witteman.C-Reactive Protein Predicts Progression of Atherosclerosis Measured at Various Sites in the Arterial Tree: The Rotterdam Study[J].Stroke: Journal of the American Heart Association.2002(12)
4Mario Di Napoli,Francesca Papa,Vittorio Bocola.C-Reactive Protein in Ischemic Stroke: An Independent Prognostic Factor[J].Stroke: Journal of the American Heart Association.2001(4)
5Blagojevic A,Delaney JA,Levesque LE,et al.Investigation of an interaction between statins and elopidogrel after percutane- ous coronary intervention:a cohort study[J].Pharmacoepide- miol Drug Saf,2009,18(5):362-369.
6Chu AY,Guilianini F,Barratt BJ,et al.Pharmacogenetic deter- minants of statin induced reductions in C-reactive protein[J].Cire Cardiovasc Genet,2012,5(1):58-65.
7Nozue T,Yamamoto S,Tohyama S,et al.Treatment with sta- tin on atheroma regression evaluated by intravascular ultra- sound with virtual histology(TRUTH Study):rationale and design[J].Circ J,2009,73(2):352-355.
